Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Califf

Showing results (1-10 of 770) with videos related to

Pageof 77
Sort By:
Journal of Cardiac Failure|November 9, 2021
The Ecosystem to Support People With Heart FailureRobert M Califf
JAMA Cardiology|August 30, 2025
Evidence About Benefits and Risks of Vaccines: Challenges in Science, Medicine, Public Health, and CultureRobert M Califf
Statistics in Medicine|September 27, 2002
Evaluating the costs and effectiveness of cardiovascular therapies: who cares about economic analyses?Robert M Califf
JACC. Heart Failure|March 14, 2014
Better late than never: a welcome publication of tardy clinical trial resultsRobert M Califf
ACP Journal Club|March 4, 2008
Review: PCI has lower risk for procedural stroke but higher risks for angina and repeated revascularization than CABGRobert M Califf
American Heart Journal|February 9, 2002
Publication policy, informed consent, and the randomized clinical trialRobert M Califf
Journal of the American College of Cardiology|February 12, 2013
Conflicting information about conflict of interestRobert M Califf
American Heart Journal|March 5, 2013
Attribution of causality in clinical research: an important element for learning health systemsRobert M Califf
American Heart Journal|November 27, 2008
The benefits of moving quality to a national levelRobert M Califf
JAMA Internal Medicine|October 27, 2025
Evidence, Opinion, and Uncertainty About COVID-19 VaccinesRobert M Califf
Pageof 77

Showing results (1-10 of 770) with videos related to

Sort By:
Pageof 77
Journal of Cardiac Failure|November 9, 2021
The Ecosystem to Support People With Heart FailureRobert M Califf
JAMA Cardiology|August 30, 2025
Evidence About Benefits and Risks of Vaccines: Challenges in Science, Medicine, Public Health, and CultureRobert M Califf
Statistics in Medicine|September 27, 2002
Evaluating the costs and effectiveness of cardiovascular therapies: who cares about economic analyses?Robert M Califf
JACC. Heart Failure|March 14, 2014
Better late than never: a welcome publication of tardy clinical trial resultsRobert M Califf
ACP Journal Club|March 4, 2008
Review: PCI has lower risk for procedural stroke but higher risks for angina and repeated revascularization than CABGRobert M Califf
American Heart Journal|February 9, 2002
Publication policy, informed consent, and the randomized clinical trialRobert M Califf
Journal of the American College of Cardiology|February 12, 2013
Conflicting information about conflict of interestRobert M Califf
American Heart Journal|March 5, 2013
Attribution of causality in clinical research: an important element for learning health systemsRobert M Califf
American Heart Journal|November 27, 2008
The benefits of moving quality to a national levelRobert M Califf
JAMA Internal Medicine|October 27, 2025
Evidence, Opinion, and Uncertainty About COVID-19 VaccinesRobert M Califf
Pageof 77